These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 363002)

  • 1. Guidelines of the Food and Drug Administration for study of new drugs in human subjects.
    Crout JR
    Ann Intern Med; 1978 Nov; 89(5 Pt 2 Suppl):832-4. PubMed ID: 363002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the Food and Drug Administration Modernization Act on the recruitment of children for research.
    Sharav VH
    Ethical Hum Sci Serv; 2003; 5(2):83-108. PubMed ID: 15279010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Federal regulation: philosophy and practice.
    Christensen CN
    Ann Intern Med; 1978 Nov; 89(5 Pt 2 Suppl):835-7. PubMed ID: 363003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing requirements for evaluation of pharmacologic agents.
    Chesney RW; Christensen ML
    Pediatrics; 2004 Apr; 113(4 Suppl):1128-32. PubMed ID: 15060209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence used for approval of new drugs.
    Botstein P
    Isr J Med Sci; 1986; 22(3-4):197-200. PubMed ID: 3528042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials of drugs from the viewpoint of the pharmaceutical industry.
    Peltier HC
    Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 2):637-42. PubMed ID: 1102239
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidelines for evaluating new antimicrobial agents.
    Gilbert DN
    J Infect Dis; 1987 Dec; 156(6):934-41. PubMed ID: 3316417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric drug development in anesthesiology: an FDA perspective.
    Schultheis LW; Mathis LL; Roca RA; Simone AF; Hertz SH; Rappaport BA
    Anesth Analg; 2006 Jul; 103(1):49-51. PubMed ID: 16790624
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug marketing exclusivity under United States and European Union law.
    Junod V
    Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347
    [No Abstract]   [Full Text] [Related]  

  • 10. EU law mandates drug testing in children.
    Sinha G
    J Natl Cancer Inst; 2008 Jan; 100(2):84-5. PubMed ID: 18182609
    [No Abstract]   [Full Text] [Related]  

  • 11. The Food and Drug Administration's requirements for approval of new dental drugs.
    Gilkes CC
    Symp Pharmacol Ther Toxicol Group; 1975 Apr; ():5-12. PubMed ID: 1064180
    [No Abstract]   [Full Text] [Related]  

  • 12. Accelerated approval of oncology drugs: can we do better?
    Ellenberg SS
    J Natl Cancer Inst; 2011 Apr; 103(8):616-7. PubMed ID: 21422401
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiarrhythmic drug approval--an industry perspective.
    Jacobs S
    Can J Cardiol; 1991; 7(1):45-6; discussion 49-50. PubMed ID: 2025792
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic significance of the drug lag.
    Daniels CE; Wertheimer AI
    Med Care; 1980 Jul; 18(7):754-65. PubMed ID: 7401721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drug applications: how long to gain approval?
    Spivey RN; Lasagna L; Trimble AG
    Clin Pharmacol Ther; 1985 Apr; 37(4):361-6. PubMed ID: 3978995
    [No Abstract]   [Full Text] [Related]  

  • 16. Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industry.
    Siegfried EC; Jaworski JC; Eichenfield LF; Paller A; Hebert AA; Simpson EL; Altman E; Arena C; Blauvelt A; Block J; Boguniewicz M; Chen S; Cordoro K; Hanna D; Horii K; Hultsch T; Lee J; Leung DY; Lio P; Milner J; Omachi T; Schneider C; Schneider L; Sidbury R; Smith T; Sugarman J; Taha S; Tofte S; Tollefson M; Tom WL; West DP; Whitney L; Zane L
    Pediatr Dermatol; 2018 May; 35(3):303-322. PubMed ID: 29600515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the U.S. Food and Drug Administration review process: clinical trial endpoints in oncology.
    McKee AE; Farrell AT; Pazdur R; Woodcock J
    Oncologist; 2010; 15 Suppl 1():13-8. PubMed ID: 20237212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food and Drug Administration requirements for approval of new anticancer drugs.
    Johnson JR; Temple R
    Cancer Treat Rep; 1985 Oct; 69(10):1155-9. PubMed ID: 4042094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prescription for monitoring drugs.
    Marshall E
    Science; 1980 Feb; 207(4433):853-5. PubMed ID: 7355265
    [No Abstract]   [Full Text] [Related]  

  • 20. Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission.
    Joffe S; Lynch HF
    N Engl J Med; 2018 Feb; 378(8):695-697. PubMed ID: 29320302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.